Imidapril: will fewer adverse events translate into better long-term outcomes?

Drugs. 2007;67(9):1379-82. doi: 10.2165/00003495-200767090-00009.
No abstract available

Publication types

  • Comment

MeSH terms

  • Angiotensin-Converting Enzyme Inhibitors / adverse effects
  • Angiotensin-Converting Enzyme Inhibitors / pharmacology
  • Angiotensin-Converting Enzyme Inhibitors / therapeutic use
  • Blood Pressure / drug effects
  • Clinical Trials as Topic
  • Humans
  • Hypertension / drug therapy*
  • Hypertension / physiopathology
  • Imidazolidines / adverse effects*
  • Imidazolidines / therapeutic use*
  • Treatment Outcome

Substances

  • Angiotensin-Converting Enzyme Inhibitors
  • Imidazolidines
  • imidapril